Masseter Botox or Buccal Fat Removal? Two Very Different Routes to a Slimmer Lower Face

Patients who want a slimmer lower face are usually offered one of two procedures: masseter reduction with botulinum toxin or buccal fat pad removal. They are frequently discussed as if they were interchangeable. Mechanically, they have almost nothing in common, and choosing the wrong one is a leading source of regret in facial contouring.

What each procedure actually targets

The masseter is the thick chewing muscle that runs from the cheekbone to the angle of the jaw. In some people, particularly those who clench or grind their teeth, it hypertrophies the way any overworked muscle does, and the result is a square or flared jaw angle. Botulinum toxin injected into the muscle blocks acetylcholine release at the neuromuscular junction. The muscle contracts less, and over 6 to 12 weeks it atrophies from disuse, typically shrinking by roughly 20 to 30 percent in volume on imaging studies. The effect is temporary. Function returns as new nerve terminals sprout, which is why treatment is repeated every 4 to 6 months, often with longer intervals over time as the muscle deconditions.

The buccal fat pad is something else entirely. It is a deep, encapsulated fat compartment that sits in the mid to lower cheek, between the masseter and the buccinator muscle. It contributes to fullness below the cheekbone, the area people describe as chipmunk cheeks. Buccal fat removal is a surgical procedure, usually done through a small incision inside the mouth, in which a portion of the pad is teased out and excised. It is permanent. That fat does not regenerate.

How a clinician tells the two apart in the chair

The diagnostic step is simple and worth knowing. If the width is at the jaw angle, near the ear and along the mandible, and the bulge firms up when the patient clenches their teeth, that is muscle. If the fullness sits higher and more forward, in the soft central cheek below the cheekbone, and does not change with clenching, that is more likely buccal fat, subcutaneous fat, or both. Asking a patient to bite down while palpating is the fastest screen in facial aesthetics. A hypertrophic masseter feels like a tensed bicep. Buccal fullness stays soft.

Bone matters too. Some square jaws are skeletal, driven by a flared mandibular angle rather than muscle bulk. Toxin will do little there, and honest assessment sometimes means telling a patient that neither procedure fits.

Reversibility, and why it matters more than people think

Masseter toxin is self-correcting. If the patient dislikes the result, or if the face looks gaunt, function and volume return within months. Buccal fat removal offers no such exit. The buccal pad naturally shrinks with age, which is part of why older faces hollow in the mid cheek. Removing it at 25 can look sharp at 25 and skeletal at 45. Facial plastic surgeons increasingly describe buccal fat removal as a procedure that borrows definition from the future, appropriate mainly for patients with genuinely excessive buccal volume that has persisted at a stable adult weight, not for lean faces chasing extra sharpness from social media reference photos.

Risk profiles are not equivalent

Masseter toxin risks are mostly functional and transient: temporary chewing fatigue, a change in smile if toxin diffuses into the risorius or zygomaticus muscles, and in rare cases paradoxical bulging of untreated muscle fibers. Technique matters, injections stay in the lower posterior bulk of the muscle to avoid smile muscles. There is also a dental consideration: reduced clenching force can genuinely help bruxism symptoms, which is why the same injection is used therapeutically for jaw pain.

Buccal fat removal is surgery near real anatomy. The parotid duct and buccal branches of the facial nerve travel through the region. Complications are uncommon in experienced hands but include asymmetry, hematoma, duct injury, and over-resection, which cannot be undone without fat grafting later.

The overlap case: when patients need neither, or both

Many patients presenting for lower face slimming actually have generalized subcutaneous fullness related to weight, which responds better to weight change or, in select cases, deoxycholic acid or energy-based fat reduction in the submental area. Others have both a strong masseter and a full buccal pad. Sequencing matters: clinicians often treat the muscle first, because it is reversible and because a 20 to 30 percent masseter reduction changes the whole lower third enough that patients frequently cancel the surgery they thought they needed.

The takeaway

Masseter toxin narrows the jaw angle by shrinking muscle, temporarily and reversibly. Buccal fat removal debulks the mid cheek, permanently. The clench test, the location of fullness, and the patient's age and leanness drive the decision. When in doubt, the reversible option first is not a compromise, it is the standard of careful practice.